Prosecution Insights
Last updated: April 19, 2026

Arvinas Operations, Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
2
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18493773 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF ANDROGEN RECEPTOR BAUER, NICOLA MARIA 1621 Non-Final OA Oct 24, 2023
18490704 MODULATORS OF BCL6 PROTEOLYSIS AND ASSOCIATED METHODS OF USE VAJDA, KRISTIN ANN 1622 Non-Final OA Oct 19, 2023
18456718 IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE RICCI, CRAIG D 1611 Final Rejection Aug 28, 2023
17548842 METHODS OF TREATING BREAST CANCER WITH TETRAHYDRONAPHTHALENE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADER RAMACHANDRAN, UMAMAHESWARI 1627 Non-Final OA Dec 13, 2021
17484628 IMIDE-BASED MODULATORS OF PROTEOLYSIS AND ASSOCIATED METHODS OF USE IVANOVA, SVETLANA M 1627 Final Rejection Sep 24, 2021

Managing Arvinas Operations, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month